3,980 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2319602/arcus-biosciences-inc-rcus-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319602 Aug 08, 2024 - Arcus Biosciences (RCUS) delivered earnings and revenue surprises of 0% and 26.08%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
RCI Hospitality (RICK) Reports Q3 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2319604/rci-hospitality-rick-reports-q3-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319604 Aug 08, 2024 - RCI Hospitality (RICK) delivered earnings and revenue surprises of -163.64% and 1.74%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Cibus (CBUS) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2319613/cibus-cbus-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319613 Aug 08, 2024 - Cibus (CBUS) delivered earnings and revenue surprises of -40.74% and 90.46%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2319594/tarsus-pharmaceuticals-inc-tars-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319594 Aug 08, 2024 - Tarsus Pharmaceuticals (TARS) delivered earnings and revenue surprises of 10.20% and 30.41%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
GrowGeneration (GRWG) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2319595/growgeneration-grwg-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319595 Aug 08, 2024 - GrowGeneration (GRWG) delivered earnings and revenue surprises of -25% and 1.01%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Rackspace (RXT) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2319578/rackspace-rxt-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319578 Aug 08, 2024 - Rackspace (RXT) delivered earnings and revenue surprises of 27.27% and 2.36%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Arlo Technologies (ARLO) Tops Q2 Earnings and Revenue Estimates https://www.zacks.com/stock/news/2319583/arlo-technologies-arlo-tops-q2-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319583 Aug 08, 2024 - Arlo Technologies (ARLO) delivered earnings and revenue surprises of 11.11% and 1.64%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Cardiff Oncology (CRDF) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2319584/cardiff-oncology-crdf-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319584 Aug 08, 2024 - Cardiff Oncology (CRDF) delivered earnings and revenue surprises of -4% and 35.83%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2319563/nektar-therapeutics-nktr-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319563 Aug 08, 2024 - Nektar (NKTR) delivered earnings and revenue surprises of -19.05% and 36.26%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2319565/codexis-cdxs-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319565 Aug 08, 2024 - Codexis (CDXS) delivered earnings and revenue surprises of -23.08% and 4.51%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Pages: 1...7374757677787980818283...398

<<<Page 78>